๐ฐ Nancy Simonian News
Page 2 - Nancy Simonian News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nancy Simonian. Real-time updates on events, politics, business and more.
August 8, 2023
-- On track to announce initial randomized data from SELECT-AML-1 trial in 4Q 2023 -- -- Expect to complete enrollment of 190 patients in SELECT-MDS-1 trial in 4Q 2023; pivotal CR data expected in...
June 2, 2023
/PRNewswire/ -- Cureยฎ, a healthcare innovation campus in New York City, today announced a one-of-a-kind Super Session featuring experts focused on leveraging...
May 13, 2023
Operator: Good morning, and welcome to Syros Pharmaceuticals First Quarter 2023 Financial Results Conference Call. [Operator Instructions].
May 10, 2023
-- On track to complete enrollment of 190 patients in 4Q 2023, with pivotal complete response data from SELECT-MDS-1 expected in 3Q 2024 -- -- Amended SELECT-MDS-1 study to add overall survival as... | May 10, 2023
September 19, 2022
Stockholders of Syros Pharmaceuticals and Bedminsterโs TYME Technologies approved plans for a previously announced $60 million merger.
July 5, 2022
Combined Company Will Operate as Syros Pharmaceuticals and Continue to Advance Syrosโ Ongoing Clinical ProgramsSyros Expects to Have Cash Into 2025; At Least a Year Past SELECT-MDS-1 Pivotal DataNow Planning to Initiate Phase 3 Clinical Trial of SY-2101 in APL 2H 2023Syros to Host Conference Call at 8:30 AM ET Today...
July 5, 2022
Syros Pharmaceuticals and Bedminster-based TYME Technologies Inc. entered into a definitive merger agreement, whereby Syros will acquire TYME
June 23, 2022
Basel, Switzerland (PRWEB) June 23, 2022 -- Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that
March 15, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.